Stephen R. Marder, M.D.

Response to Subcutaneous Injectable Monthly Risperidone (RBP-7000): PANSS Item-Level Analysis

September 21, 2021

Phase 3 study data on the efficacy of RBP-7000 for schizophrenia were examined to see if dose-response relationships exist for different items of the Positive and Negative Syndrome Scale.

Anne Le Moigne, John Csernansky, Robert A. Leadbetter, et al

Consensus Statement

Consensus on Monitoring Blood Antipsychotic Levels

May 19, 2020

The quantification of antipsychotic levels in blood, or therapeutic drug monitoring (TDM), could aid clinicians in numerous challenging scenarios. Learn more about using TDM for dosing decisions in this...

Georgios Schoretsanitis, John M. Kane, Christoph U. Correll, et al

Article

Consensus Recommendations for Assessing Suicidal Ideation and Behavior

June 28, 2017

Industry experts gathered to develop guidance for standardized data collection and analysis of suicidal ideation and to guide the development of novel treatments in an effort to rectify the...

Phillip B. Chappell, Michelle Stewart, Larry Alphs, et al

Original Research

Clozapine and Risperidone in Moderately Refractory Schizophrenia: A 6-Month Randomized Double-Blind Comparison

May 25, 2016

Nina R. Schooler, Stephen R. Marder, K. N. R. Chengappa, et al

Educational Activity

Monitoring Treatment and Managing Adherence in Schizophrenia

October 15, 2013

Stephen R. Marder

Educational Activity

Clinician Perceptions, Expectations, and Management of Negative Symptoms in Schizophrenia

January 15, 2013

Stephen R. Marder

Original Research

Antipsychotic Medications & Schizophrenia

December 15, 2011

Explore an analysis on Mid-Term and Long-Term Efficacy and Effectiveness of Antipsychotic Medications for Schizophrenia.

Ira D. Glick, Christoph U. Correll, A. Carlo Altamura, et al

Book Review

Medical Illness and Schizophrenia, 2nd ed

December 15, 2010

Stephen R. Marder

Original Research

Case Reports of Postmarketing Adverse Event Experiences With Olanzapine Intramuscular Treatment in Patients With Agitation

February 9, 2010

Stephen R. Marder, Sebastian Sorsaburu, Eduardo Dunayevich, et al

Original Research

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of Adjunctive Aripiprazole for Schizophrenia or Schizoaffective Disorder Inadequately Treated With Quetiapine or Risperidone Monotherapy

October 15, 2009

John M. Kane, Christoph U. Correll, Donald C. Goff, et al

Book Review

Research Methods in Psychiatry, 3rd ed

January 15, 2009

Stephen R. Marder

Original Research

The Acute Efficacy of Aripiprazole Across the Symptom Spectrum of Schizophrenia: A Pooled Post Hoc Analysis From 5 Short-Term Studies

December 2, 2008

Philip G. Janicak, Ira D. Glick, Stephen R. Marder, et al

Response to Subcutaneous Injectable Monthly Risperidone (RBP-7000): PANSS Item-Level Analysis

Consensus on Monitoring Blood Antipsychotic Levels

Consensus Recommendations for Assessing Suicidal Ideation and Behavior

Clozapine and Risperidone in Moderately Refractory Schizophrenia: A 6-Month Randomized Double-Blind Comparison

Monitoring Treatment and Managing Adherence in Schizophrenia

Clinician Perceptions, Expectations, and Management of Negative Symptoms in Schizophrenia

Antipsychotic Medications & Schizophrenia

Medical Illness and Schizophrenia, 2nd ed

Case Reports of Postmarketing Adverse Event Experiences With Olanzapine Intramuscular Treatment in Patients With Agitation

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of Adjunctive Aripiprazole for Schizophrenia or Schizoaffective Disorder Inadequately Treated With Quetiapine or Risperidone Monotherapy

Research Methods in Psychiatry, 3rd ed

The Acute Efficacy of Aripiprazole Across the Symptom Spectrum of Schizophrenia: A Pooled Post Hoc Analysis From 5 Short-Term Studies

ELSEWHERE:

FOLLOW US:

Stephen R. Marder, M.D.

Response to Subcutaneous Injectable Monthly Risperidone (RBP-7000): PANSS Item-Level Analysis

Consensus on Monitoring Blood Antipsychotic Levels

Consensus Recommendations for Assessing Suicidal Ideation and Behavior

Clozapine and Risperidone in Moderately Refractory Schizophrenia: A 6-Month Randomized Double-Blind Comparison

Monitoring Treatment and Managing Adherence in Schizophrenia

Clinician Perceptions, Expectations, and Management of Negative Symptoms in Schizophrenia

Antipsychotic Medications & Schizophrenia

Medical Illness and Schizophrenia, 2nd ed

Case Reports of Postmarketing Adverse Event Experiences With Olanzapine Intramuscular Treatment in Patients With Agitation

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of Adjunctive Aripiprazole for Schizophrenia or Schizoaffective Disorder Inadequately Treated With Quetiapine or Risperidone Monotherapy

Research Methods in Psychiatry, 3rd ed

The Acute Efficacy of Aripiprazole Across the Symptom Spectrum of Schizophrenia: A Pooled Post Hoc Analysis From 5 Short-Term Studies

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles